| scholarly article | Q13442814 |
| P2093 | author name string | Kei Sato | |
| Hiroshi Miyamoto | |||
| Itaru Endo | |||
| Norio Yukawa | |||
| Kuniya Tanaka | |||
| Sho Sato | |||
| Chikara Kunisaki | |||
| Hirotoshi Akiyama | |||
| Takashi Kosaka | |||
| Yusaku Tanaka | |||
| Hideaki Suematsu | |||
| P2860 | cites work | Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer | Q84851081 |
| Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancer | Q87121238 | ||
| Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer | Q87627644 | ||
| New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world | Q29614969 | ||
| Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data | Q33203756 | ||
| Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma | Q33866015 | ||
| Nutritional Management of Patients With Esophageal and Esophagogastric Junction Cancer | Q33887613 | ||
| Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer | Q35341867 | ||
| Gastrointestinal cancers in Europe | Q35553221 | ||
| Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery | Q36278088 | ||
| Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. | Q36613902 | ||
| Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer | Q36695064 | ||
| A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma. | Q37038184 | ||
| Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer | Q38823020 | ||
| Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer | Q39063631 | ||
| Preoperative sarcopenia is a predictor of postoperative pulmonary complications in esophageal cancer following esophagectomy: A retrospective cohort study | Q40601580 | ||
| Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study | Q40648872 | ||
| Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer | Q40874943 | ||
| Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma | Q41628770 | ||
| Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma | Q43188323 | ||
| Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index | Q43528838 | ||
| Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer | Q43940756 | ||
| Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment | Q46058203 | ||
| Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? | Q47282777 | ||
| Association of Preoperative Nutritional Status with Prognosis in Patients with Esophageal Cancer Undergoing Salvage Esophagectomy | Q49642983 | ||
| Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. | Q50472879 | ||
| Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer. | Q51026862 | ||
| Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer. | Q51641752 | ||
| Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. | Q51751284 | ||
| Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. | Q53065998 | ||
| Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients. | Q53471171 | ||
| Clinical Assessment of Sarcopenia and Changes in Body Composition During Neoadjuvant Chemotherapy for Esophageal Cancer. | Q53490032 | ||
| Esophageal Cancer | Q56209683 | ||
| Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer | Q57314903 | ||
| [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 | ||
| P433 | issue | 3 | |
| P921 | main subject | chemoradiotherapy | Q5090613 |
| esophageal cancer | Q372701 | ||
| sarcopenia | Q1787939 | ||
| P304 | page(s) | 603-610 | |
| P577 | publication date | 2018-05-01 | |
| P1433 | published in | In Vivo | Q15749806 |
| P1476 | title | Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy. | |
| P478 | volume | 32 |
| Q91651767 | Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy |
| Q90394801 | Myosteatosis in a systemic inflammation-dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer |
| Q90633510 | Prognostic Significance of Sarcopenia in Patients with Unresectable Advanced Esophageal Cancer |
| Q90102281 | Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin |
| Q90151639 | Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study |
Search more.